Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...

Shares of Novo Nordisk A/S fell after the Danish drugmaker reported mixed safety data on one of its next-generation ...

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...

Novo Nordisk's U.S.-listed shares lost ground Friday after a study of the pharmaceutical firm’s latest obesity treatment ...

Based on the results of the trial, drugmaker Novo Nordisk has asked ... children who received the drug slowed weight gain to ...

Novo Nordisk reported that its new obesity pill led to substantial weight loss in an early study, boosting the company’s ...

Novo Nordisk's weight loss drug, Saxenda, helped children ages six to 11 reduce their body mass index in a recent trial.

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

Novo Nodrisk’s cannabinoid receptor–targeting obesity pill was picked up in the $1.1 billion acquisition of Inversago ...

Ozempic maker Novo Nordisk on Wednesday said data showed ... Amycretin targets the same GLP-1 hormone as other weight loss and diabetes drugs like Novo’s Ozempic and Wegovy and Lilly’s ...

Novo Nordisk has lifted the lid on a phase 1 trial of its oral amylin and GLP-1 receptor co-agonist, linking the candidate to ...

Novo Nordisk, which also manufactures semaglutide ... who are at risk of developing conditions like diabetes. WEIGHT-LOSS DRUGS COULD REDUCE COVID-RELATED DEATHS: STUDY Dr. Pat Basu, managing ...